FATE THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

14 1 2025 09:45:18 提供 NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

13 1 2025 09:45:04 提供 NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

10 1 2025 10:22:09 提供 NetDania Notify

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

03 1 2025 16:01:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

30 12 2024 09:52:19 提供 NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

26 12 2024 13:03:48 提供 NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

23 12 2024 10:24:21 提供 NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

19 12 2024 10:10:18 提供 NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

18 12 2024 09:46:00 提供 NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

13 12 2024 09:45:20 提供 NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

12 12 2024 10:17:16 提供 NetDania Notify

Fate Therapeutics Presents New Phase 1 Clinical Data of FT819 Off-the-shelf, CAR T-cell Product Candidate for Systemic Lupus Erythematosus

09 12 2024 16:01:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

03 12 2024 16:01:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics Announces Leadership Transition

29 11 2024 13:05:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming December Investor Conferences

26 11 2024 16:01:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics Presents 6-Month Follow-up Data on First Patient Treated in Phase 1 Autoimmunity Study with Fludarabine-free Conditioning and FT819 Off-the-shelf, 1XX CAR T-cell Product Candidate at ACR Convergence

18 11 2024 08:05:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics Highlights FT522 Off-the-shelf, ADR-armed CAR NK Cell Product Candidate at 2024 ACR Convergence

18 11 2024 08:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

15 11 2024 09:46:29 提供 NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

14 11 2024 09:54:48 提供 NetDania Notify

Fate Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates

12 11 2024 16:01:00 提供 Nasdaq GlobeNewswire